NA
BLU

Neuburgh Advisers’s BELLUS Health Inc. BLU Stock Holding History

Neuburgh Advisers’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$23K Buy
+3,552
New +$25.1K ﹤0.01% 881

Other funds holding BLU

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Neuburgh Advisers's BLU Position: Q3 2019 in Review

Neuburgh Advisers opened a new position in BELLUS Health Inc. (BLU) in Q3 2019: 3,552 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #881 among its holdings.

40 funds tracked by Wall St. Rank hold BLU as of Q3 2019.

  • Neuburgh Advisers held 3,552 shares of BELLUS Health Inc. worth $23K as of Q3 2019.
  • BELLUS Health Inc. was a new Neuburgh Advisers position in Q3 2019.
  • BELLUS Health Inc. made up ﹤0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #881 holding.
  • 40 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.